Keyphrases
Pharmacokinetics
64%
Indocyanine Green
30%
Fentanyl
30%
Recirculatory
29%
Cardiac Output
26%
Antipyrine
25%
Thiopental
22%
Pharmacokinetic Model
21%
Postanesthesia Care Unit
17%
Plasma Concentration
17%
Inulin
16%
Blood Flow
15%
Elimination Clearance
15%
Cardiac Surgical Patients
15%
Distribution Kinetics
14%
Pharmacodynamics
14%
Morphine
14%
Cardiopulmonary Bypass
14%
Train-of-four Ratio
13%
Drug Distribution
12%
Total Body Water
12%
Postoperative Day
11%
Pharmacokinetic Study
11%
Anesthesia
11%
Methadone
11%
Surgical Patients
11%
Rocuronium
11%
Cardiac Surgery
11%
Opioids
10%
Randomized Controlled Trial
10%
Pancuronium
10%
Residual Neuromuscular Blockade
10%
Blood Samples
10%
Pregnant Women
9%
Midazolam
9%
Postoperative Pain
9%
Neuromuscular Blocking Agents
9%
Blood Volume
9%
Clinical Recovery
9%
Muscle Weakness
9%
Alfentanil
9%
Anesthesia Induction
9%
Extracellular Volume
8%
Ketamine
8%
Bolus
8%
Aerosol
8%
Etomidate
8%
Urea
8%
δ-Aminolevulinic Acid Dehydratase
8%
Single Breath
8%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacokinetics
100%
Indocyanine Green
32%
Elimination
28%
Phenazone
24%
Duragesic
23%
Pharmacodynamics
21%
Inulin
19%
Sodium Thiopental
19%
Morphine
15%
Drug Distribution
13%
Rocuronium
11%
Pancuronium
11%
Placebo
11%
Midazolam
11%
Postoperative Pain
8%
Bioavailability
8%
Methadone
8%
Paracetamol
8%
Muscle Weakness
8%
Drug Concentration
8%
Ketamine
8%
Dexamethasone
8%
Halothane
7%
Dose-Response Relationship
7%
Volume of Distribution
6%
Normal Human
6%
Neuromuscular Blocking Agent
6%
Alfentanil
5%
Fentanyl Citrate
5%
Etomidate
5%
Randomized Controlled Trial
5%
Selective Serotonin Reuptake Inhibitor
5%
Porphobilinogen Synthase
5%
Prochlorperazine
5%
Phenylephrine
5%
Gallamine
5%
Vecuronium
5%
Sertraline
5%
Fluoxetine
5%
Citalopram
5%
Analgesic Agent
5%
Propranolol
5%
Medicine and Dentistry
Neuromuscular Blocking
20%
Fentanyl
19%
Heart Surgery
19%
Post-Anesthesia Care Unit
18%
Cardiopulmonary Bypass
14%
Methadone
11%
Postoperative Pain
11%
Rocuronium
11%
Extubation
10%
Randomized Controlled Trial
10%
Placebo
9%
Morphine
9%
Muscle Weakness
9%
Spinal Fusion
8%
Pancuronium
8%
Neuromuscular Blocking Agent
8%
Clinical Trial
6%
Intensive Care Unit
6%
Neuromuscular Function
6%
Fatty Acid Desaturation
5%
Pharmacokinetics
5%
Neostigmine
5%
Paracetamol
5%
Dexamethasone
5%
Sertraline
5%
Fluoxetine
5%